• -
85 Results
A globe lies next to the diaphragm of a stethoscope.
Mosquito-transmitted Epidemics: Dengue, Chikungunya and West Nile in the United States and Mexico
This policy brief urges collaboration between the United States and Mexico to address widespread epidemics of mosquito-transmitted diseases like West Nile, dengue and chikungunya in both countries. Such policy development should focus on vector control programs, public awareness and the development of vaccines to curb the spread of these diseases.
Kirstin R.W. Matthews, Jennifer R. Herricks December 16, 2015
U.S. Health Care Technologies
Advancements in technology have increased access to health information and self-monitoring for individual consumers, as well as increased health care providers’ ability to diagnose, monitor or treat their patients remotely. This summary provides a snapshot of the scope of health-related technology available on the market and may provide insight into the current needs or demands of patients and providers.
Quianta Moore May 31, 2015
Vaccine
Human Papillomavirus Vaccine: A Public Health Opportunity for Texas
The human papillomavirus (HPV) affects over 80 million Americans, causing more than 40,000 cases of HPV-associated cancers in the U.S. In 2006, the FDA licensed the first HPV vaccine, which could help save thousands of lives; no cure for HPV currently exists. However, the political controversy raised by the vaccine has limited its acceptance and use. Such resistance potentially jeopardizes an opportunity to reduce cancer rates in Texas and the broader United States.
Kirstin R.W. Matthews, Monica M. Matsumoto October 6, 2014
blood bags
Cord Blood Banking in the United States: A Public Need for Policy Commitments
Stem cells from umbilical cord blood (CB) can be used to treat over 80 different diseases, including many types of leukemia, lymphoma and inherited immune system disorders. Extensive storage facilities in the United States and around the world collect, test and freeze CB for later use in medical procedures. However, the divide between two different banking models — public versus private — presents policy challenges. This policy report examines the difference between public and private cord blood banks and offers recommendations for US policymakers to improve cord blood banking and ensure high quality standards.
Monica M. Matsumoto, Kirstin R.W. Matthews October 6, 2014